SELLAS LIFE SCIENCES GROUP I (SLS) Stock Income Statement
NASDAQ:SLS - Nasdaq - US81642T2096 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.00M | 7.60M | |||
| Cost Of Goods | N/A | N/A | 0.00 | 100.00K | 200.00K | |||
| Gross Profit | N/A | N/A | 0.00 | 900.00K | 7.40M | |||
| Operating Expenses | 27.93M | 32.00M | 37.87M | 32.85M | 26.99M | |||
| Research and Development | 17.19M | N/A | 24.01M | 20.27M | 15.67M | |||
| Selling, General, and Administrative Expenses | 10.75M | 12.00M | 13.86M | 12.58M | 11.32M | |||
| Operating Income | -27.93M | -32.00M | -37.87M | -31.95M | -19.59M | |||
| Interest Income/Expense | 803.00K | N/A | 525.00K | 350.00K | 20.00K | |||
| Other Income/Expense | N/A | 0.00 | 4.00K | 300.00K | 4.34M | |||
| Non Recurring Items | N/A | N/A | 0.00 | -10.00M | -5.70M | |||
| Income Before Taxes | -27.13M | -31.00M | -37.34M | -41.30M | -20.94M | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | -240.00K | |||
| Net Income | -27.13M | -31.00M | -37.34M | -41.30M | -20.70M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.39 | -0.50 | -1.34 | -2.13 | -1.34 | |||
| Non GAAP EPS | -0.38 | -0.52 | -1.36 | -2.23 | -1.33 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 90.00% | 97.37% | |||
| Profit Margin | N/A | N/A | N/A | -4130.00% | -272.37% | |||
| Operating Profit Margin | N/A | N/A | N/A | -3195.00% | -257.76% | |||
All data in USD